InvestorsHub Logo
Followers 0
Posts 21
Boards Moderated 0
Alias Born 08/07/2019

Re: None

Tuesday, 10/13/2020 8:07:34 AM

Tuesday, October 13, 2020 8:07:34 AM

Post# of 66
[Delayed] VYNE Director LePore Adopts 10b5-1 Purchasing Plan
 
  Additional News & Analysis at EZ-Insider
 
Complimentary access to this story is provided exclusively to Bloomberg users on a delayed basis.
To get real-time news stories or for a free trial of EZ-Insider, click here or call (301) 913-5100.
 
VYNE Director LePore Adopts 10b5-1 Purchasing Plan
10/8/2020
According to an 8-K filed on Oct. 7, VYNE Therapeutics Inc. (VYNE) Director Patrick G. LePore adopted his first 10b5-1 plan on Oct. 5. Under the plan, LePore may purchased up to 200,000 shares of the clinical stage biopharmaceutical company over the next 12 months, at prevailing market prices. The filing did not indicate when purchases under the plan would begin, and no other plan information was included in the filing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYNE News